Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one.

@article{Wang2009MolecularDS,
  title={Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one.},
  author={Jing-Fang Wang and Ke Gong and Dongqing Wei and Yi-Xue Li and Kuo-Chen Chou},
  journal={Protein engineering, design \& selection : PEDS},
  year={2009},
  volume={22 6},
  pages={
          349-55
        }
}
Protein tyrosine phosphatases 1B (PTP1B) is a major negative regulator of both insulin and leptin signaling pathways. In view of this, it becomes an important target for drug development against cancers, diabetes and obesity. The aim of the current study is to use the long time-scale molecular dynamics (MD) simulations to investigate the structural and dynamic factors that cause its inhibition by INTA and INTB, the two most potent and highly selective PTP1B inhibitors known so far. In order to… Expand
Computational revelation of binding mechanisms of inhibitors to endocellular protein tyrosine phosphatase 1B using molecular dynamics simulations
TLDR
Endocellular protein tyrosine phosphatase 1B (PTP1B) is one of the most promising target for designing and developing drugs to cure type-II diabetes and obesity, and it is found that three inhibitors can generate hydrogen bonding interactions and hydrophobic interactions with different residues of PTP 1B, which provide important forces for associations of inhibitors with PTP1 B. Expand
Molecular dynamics simulation of the interaction between protein tyrosine phosphatase 1B and aryl diketoacid derivatives.
TLDR
This study provides a more thorough understanding of the PTP-1B inhibitor binding processes and indicates that the van der Waals interactions cooperate with the hydrogen bond interactions. Expand
Structural Basis of Fullerene Derivatives as Novel Potent Inhibitors of Protein Tyrosine Phosphatase 1B: Insight into the Inhibitory Mechanism through Molecular Modeling Studies
TLDR
Theoretical results provide useful clues for further investigation of the noval inhibitors of PTP1B at the nanoscale and suggest that compound 1, like compound 2, is a competitive inhibitor since it blocks the active site to prevent the binding of the substrate. Expand
Design, Synthesis, Biological Activity and Molecular Dynamics Studies of Specific Protein Tyrosine Phosphatase 1B Inhibitors over SHP-2
  • Su-xia Sun, Xiao-bo Li, +5 authors Wei Liu
  • Chemistry, Medicine
  • International journal of molecular sciences
  • 2013
TLDR
Small weight molecules of the imidazolidine series were screened from databases and optimized on silicon as the inhibitors of PTP1B based on the steric conformation and electronic configuration of thiazolidinedione (TZD) compounds and a novel inhibitor is reported. Expand
Alpha7 Helix Plays an Important Role in the Conformational Stability of PTP1B
TLDR
Results show that the PTP1B specific α7 is important for the conformation and dynamics of the WPD loop, and also may play a role in ligand binding. Expand
Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.
TLDR
Molecular dynamics simulations on both the open and the closed states of the wild-type and S31N mutant M2 channels in the presence of rimantadine are conducted to address the drug-resistance problem of the channel from a dynamic point of view. Expand
Modelling the molecular mechanism of protein–protein interactions and their inhibition: CypD–p53 case study
TLDR
This study attempted to model the CypD–p53 interaction in order to delineate their mode of binding and also to disclose the molecular mechanism, by means of which CsA interferes with this interaction, and identified novel CypD inhibitors through structure-based methods. Expand
A comparative study of structural and conformational properties of casein kinase-1 isoforms: insights from molecular dynamics and principal component analysis.
TLDR
The dynamical and conformational properties for each of three isoforms of CK1 are explored through molecular dynamics simulations and it is suggested that conformational subspace shifts upon binding to ligands and guides the kinase action of CK 1 isoforms. Expand
Exploration of conformational transition in the aryl-binding site of human FXa using molecular dynamics simulations
TLDR
It is proposed that an induced-fit mechanism governs the functioning of human coagulation FX, which helps provide a better understanding of the interactions between FXa and its substrate, and the mechanism of the conformational changes involved in human coAGulation. Expand
Identification of potential CCR5 inhibitors through pharmacophore-based virtual screening, molecular dynamics simulation and binding free energy analysis.
TLDR
Results suggest that the hybrid strategy would provide a basis for rational drug design for CCR5 inhibitors. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 74 REFERENCES
A molecular dynamics study of WPD-loop flexibility in PTP1B.
TLDR
It is demonstrated that BB3 not only significantly reduces the flexibility of the WPD-loop compared to both the apo-enzyme or the closed conformation complexed with phosphotyrosine, but that this is accompanied by reduced flexibility in a related region, the S-loop, further emphasising the possibility of manipulating this region when designing novel inhibitors for PTP1B. Expand
Molecular dynamics simulations of protein-tyrosine phosphatase 1B. II. substrate-enzyme interactions and dynamics.
TLDR
It is shown that internal motions in the binding pocket occur in a subspace of only a few degrees of freedom, which could explain the experimentally observed preference of PTP1B for negatively charged substrates like the DADEpYL peptide. Expand
Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design.
TLDR
Identifying a second pTyr molecule at the same site in the PTP1B/C215S-pTyr complex confirms that these residues constitute a low-affinity noncatalytic aryl phosphate-binding site, which provides a paradigm for the design of tight-binding, highly specific P TP1B inhibitors that can span both the active site and the adjacent noncatalyst site. Expand
Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.
Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of the insulin and leptin receptor pathways and thus an attractive therapeutic target for diabetes and obesity. Starting with a highExpand
Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases.
TLDR
A general, low-molecular weight PTP inhibitor can be developed into a highly selective inhibitor for PTP1B and TC-PTP by introducing a substituent, which is designed to address the region around residues 258 and 259. Expand
Crystal structure of human protein tyrosine phosphatase 1B.
TLDR
The structure of PTP1B should serve as a model for other members of the PTP family and as a framework for understanding the mechanism of tyrosine dephosphorylation. Expand
Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS☆
TLDR
It has been observed that both the above compounds interact with the active site of the SARS enzyme through six hydrogen bonds, which may provide a solid basis for subsite analysis and mutagenesis relative to rational design of highly selective inhibitors for therapeutic application. Expand
QSAR and complex network study of the chiral HMGR inhibitor structural diversity.
TLDR
The work constructs the first complex network that describes the drug-drug similarity relationships for more than 1600 experimentally non-explored chiral HMGRIs isomers, and suggests a new mixed application in the QSAR study of relevant aspects of structural diversity by using chiral/non-chiral TIs, combined with complex networks. Expand
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
TLDR
A new model for the prediction of the MAO-A and -B inhibitor activity by the use of combined complex networks and QSAR methodologies was obtained and the theoretical prediction was compared with the experimental activity data. Expand
Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design.
TLDR
The structure-activity relationships of two SNPs, W120R and I331V, with the ligands of CEC, Fluvoxamine, Lescol and Ticlopidine were investigated, providing insights into personalization of drug treatments and stimulating novel strategies for finding desired personalized drugs. Expand
...
1
2
3
4
5
...